Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008-2018

We investigated the clinical outcomes and molecular mechanisms of fluconazole-resistant (FR) Candida glabrata bloodstream infections. Among 1,158 isolates collected during multicenter studies in South Korea during 2008–2018, 5.7% were FR. For 64 patients with FR bloodstream infection isolates, the 3...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases 2021-03, Vol.27 (3), p.779-788
Main Authors: Won, Eun Jeong, Choi, Min Ji, Kim, Mi-Na, Yong, Dongeun, Lee, Wee Gyo, Uh, Young, Kim, Taek Soo, Byeon, Seung Ah, Lee, Seung Yeob, Kim, Soo Hyun, Shin, Jong Hee
Format: Article
Language:English
Subjects:
Amino acids
Antifungal agents
Antimicrobial agents
Bloodstream Isolates, South Korea, 2008–2018
Candida
Candida glabrata
candidemia
Causes of
Drug resistance in microorganisms
fluconazole resistance
Fluconazole-Resistant
fungal infections
Gene expression
Genetic aspects
Health aspects
Laboratories
Mortality
Mutation
Patient outcomes
PDR1
Septicemia
Survival analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c688t-47c3a38ed4875a2f9be13943c86e01cd4aa5cd3328cdf1101030ff086f1d35273
cites cdi_FETCH-LOGICAL-c688t-47c3a38ed4875a2f9be13943c86e01cd4aa5cd3328cdf1101030ff086f1d35273
container_end_page 788
container_issue 3
container_start_page 779
container_title Emerging infectious diseases
container_volume 27
creator Won, Eun Jeong
Choi, Min Ji
Kim, Mi-Na
Yong, Dongeun
Lee, Wee Gyo
Uh, Young
Kim, Taek Soo
Byeon, Seung Ah
Lee, Seung Yeob
Kim, Soo Hyun
Shin, Jong Hee
description We investigated the clinical outcomes and molecular mechanisms of fluconazole-resistant (FR) Candida glabrata bloodstream infections. Among 1,158 isolates collected during multicenter studies in South Korea during 2008–2018, 5.7% were FR. For 64 patients with FR bloodstream infection isolates, the 30-day mortality rate was 60.9% and the 90-day mortality rate 78.2%; these rates were significantly higher than in patients with fluconazole-susceptible dose-dependent isolates (30-day mortality rate 36.4%, 90-day mortality rate 43.8%; p
doi_str_mv 10.3201/eid2703.203482
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_3ccd79ff7cc8478e942f8f34a54809c6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A656636379</galeid><doaj_id>oai_doaj_org_article_3ccd79ff7cc8478e942f8f34a54809c6</doaj_id><sourcerecordid>A656636379</sourcerecordid><originalsourceid>FETCH-LOGICAL-c688t-47c3a38ed4875a2f9be13943c86e01cd4aa5cd3328cdf1101030ff086f1d35273</originalsourceid><addsrcrecordid>eNqNk9-LEzEQxxdRvPP01UdZEEThtubXZpMX4SyeFg8OruprmObHNmW7OTdZUf96U1vrVfogeUiYfOY7k8xMUTzFaEIJwq-tN6RBdEIQZYLcK04xEqjiqJb392eGTopHMa4QwtlFPixOKOWE1QKfFvPLbtShh5-hs9WNjT4m6FM5hd54A2XbwWKABOXbLgQT02BhXc5i6CDZeF7Ow5iW5ceQzeclQUhUOYB4XDxw0EX7ZLefFZ8v332afqiurt_PphdXleZCpIo1mgIV1jDR1ECcXFhMJaNacIuwNgyg1oZSIrRxGCOMKHIOCe6woTVp6Fkx2-qaACt1O_g1DD9UAK9-G8LQKhiS151VVGvTSOcarQVrhJWMOOEog5oJJDXPWm-2WrfjYm2Ntn0aoDsQPbzp_VK14ZtqJEG8llng5U5gCF9HG5Na-6ht10FvwxgVYZIiVFOCM_r8H3QVxqHPX6VIjaTkWNbiL9VCfoDvXchx9UZUXfCac8ppswlbHaFa29ucZOit89l8wE-O8HkZu_b6qMOrA4fMJPs9tTDGqGbzm_9nr78csi_usEsLXVrmvhqTD308mrEeQoyDdfuiYKQ2M6B2M6C2M5Adnt0t5R7_0_T0F4LO-04</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2509961958</pqid></control><display><type>article</type><title>Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008-2018</title><source>PubMed Central</source><creator>Won, Eun Jeong ; Choi, Min Ji ; Kim, Mi-Na ; Yong, Dongeun ; Lee, Wee Gyo ; Uh, Young ; Kim, Taek Soo ; Byeon, Seung Ah ; Lee, Seung Yeob ; Kim, Soo Hyun ; Shin, Jong Hee</creator><creatorcontrib>Won, Eun Jeong ; Choi, Min Ji ; Kim, Mi-Na ; Yong, Dongeun ; Lee, Wee Gyo ; Uh, Young ; Kim, Taek Soo ; Byeon, Seung Ah ; Lee, Seung Yeob ; Kim, Soo Hyun ; Shin, Jong Hee</creatorcontrib><description>We investigated the clinical outcomes and molecular mechanisms of fluconazole-resistant (FR) Candida glabrata bloodstream infections. Among 1,158 isolates collected during multicenter studies in South Korea during 2008–2018, 5.7% were FR. For 64 patients with FR bloodstream infection isolates, the 30-day mortality rate was 60.9% and the 90-day mortality rate 78.2%; these rates were significantly higher than in patients with fluconazole-susceptible dose-dependent isolates (30-day mortality rate 36.4%, 90-day mortality rate 43.8%; p&lt;0.05). For patients with FR isolates, appropriate antifungal therapy was the only independent protective factor associated with 30-day (hazard ratio 0.304) and 90-day (hazard ratio 0.310) mortality. Sequencing of pleiotropic drug-resistance transcription factor revealed that 1–2 additional Pdr1p amino acid substitutions (except genotype-specific Pdr1p amino acid substitutions) occurred in 98.5% of FR isolates but in only 0.9% of fluconazole-susceptible dose-dependent isolates. These results highlight the high mortality rate of patients infected with FR C. glabrata BSI isolates harboring Pdr1p mutations.</description><identifier>ISSN: 1080-6040</identifier><identifier>EISSN: 1080-6059</identifier><identifier>DOI: 10.3201/eid2703.203482</identifier><identifier>PMID: 33624581</identifier><language>eng</language><publisher>United States: U.S. National Center for Infectious Diseases</publisher><subject>Amino acids ; Antifungal agents ; Antimicrobial agents ; Bloodstream Isolates, South Korea, 2008–2018 ; Candida ; Candida glabrata ; candidemia ; Causes of ; Drug resistance in microorganisms ; fluconazole resistance ; Fluconazole-Resistant ; fungal infections ; Gene expression ; Genetic aspects ; Health aspects ; Laboratories ; Mortality ; Mutation ; Patient outcomes ; PDR1 ; Septicemia ; Survival analysis</subject><ispartof>Emerging infectious diseases, 2021-03, Vol.27 (3), p.779-788</ispartof><rights>COPYRIGHT 2021 U.S. National Center for Infectious Diseases</rights><rights>Published 2021. This article is a U.S. Government work and is in the public domain in the USA.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c688t-47c3a38ed4875a2f9be13943c86e01cd4aa5cd3328cdf1101030ff086f1d35273</citedby><cites>FETCH-LOGICAL-c688t-47c3a38ed4875a2f9be13943c86e01cd4aa5cd3328cdf1101030ff086f1d35273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920659/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920659/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33624581$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Won, Eun Jeong</creatorcontrib><creatorcontrib>Choi, Min Ji</creatorcontrib><creatorcontrib>Kim, Mi-Na</creatorcontrib><creatorcontrib>Yong, Dongeun</creatorcontrib><creatorcontrib>Lee, Wee Gyo</creatorcontrib><creatorcontrib>Uh, Young</creatorcontrib><creatorcontrib>Kim, Taek Soo</creatorcontrib><creatorcontrib>Byeon, Seung Ah</creatorcontrib><creatorcontrib>Lee, Seung Yeob</creatorcontrib><creatorcontrib>Kim, Soo Hyun</creatorcontrib><creatorcontrib>Shin, Jong Hee</creatorcontrib><title>Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008-2018</title><title>Emerging infectious diseases</title><addtitle>Emerg Infect Dis</addtitle><description>We investigated the clinical outcomes and molecular mechanisms of fluconazole-resistant (FR) Candida glabrata bloodstream infections. Among 1,158 isolates collected during multicenter studies in South Korea during 2008–2018, 5.7% were FR. For 64 patients with FR bloodstream infection isolates, the 30-day mortality rate was 60.9% and the 90-day mortality rate 78.2%; these rates were significantly higher than in patients with fluconazole-susceptible dose-dependent isolates (30-day mortality rate 36.4%, 90-day mortality rate 43.8%; p&lt;0.05). For patients with FR isolates, appropriate antifungal therapy was the only independent protective factor associated with 30-day (hazard ratio 0.304) and 90-day (hazard ratio 0.310) mortality. Sequencing of pleiotropic drug-resistance transcription factor revealed that 1–2 additional Pdr1p amino acid substitutions (except genotype-specific Pdr1p amino acid substitutions) occurred in 98.5% of FR isolates but in only 0.9% of fluconazole-susceptible dose-dependent isolates. These results highlight the high mortality rate of patients infected with FR C. glabrata BSI isolates harboring Pdr1p mutations.</description><subject>Amino acids</subject><subject>Antifungal agents</subject><subject>Antimicrobial agents</subject><subject>Bloodstream Isolates, South Korea, 2008–2018</subject><subject>Candida</subject><subject>Candida glabrata</subject><subject>candidemia</subject><subject>Causes of</subject><subject>Drug resistance in microorganisms</subject><subject>fluconazole resistance</subject><subject>Fluconazole-Resistant</subject><subject>fungal infections</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Laboratories</subject><subject>Mortality</subject><subject>Mutation</subject><subject>Patient outcomes</subject><subject>PDR1</subject><subject>Septicemia</subject><subject>Survival analysis</subject><issn>1080-6040</issn><issn>1080-6059</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqNk9-LEzEQxxdRvPP01UdZEEThtubXZpMX4SyeFg8OruprmObHNmW7OTdZUf96U1vrVfogeUiYfOY7k8xMUTzFaEIJwq-tN6RBdEIQZYLcK04xEqjiqJb392eGTopHMa4QwtlFPixOKOWE1QKfFvPLbtShh5-hs9WNjT4m6FM5hd54A2XbwWKABOXbLgQT02BhXc5i6CDZeF7Ow5iW5ceQzeclQUhUOYB4XDxw0EX7ZLefFZ8v332afqiurt_PphdXleZCpIo1mgIV1jDR1ECcXFhMJaNacIuwNgyg1oZSIrRxGCOMKHIOCe6woTVp6Fkx2-qaACt1O_g1DD9UAK9-G8LQKhiS151VVGvTSOcarQVrhJWMOOEog5oJJDXPWm-2WrfjYm2Ntn0aoDsQPbzp_VK14ZtqJEG8llng5U5gCF9HG5Na-6ht10FvwxgVYZIiVFOCM_r8H3QVxqHPX6VIjaTkWNbiL9VCfoDvXchx9UZUXfCac8ppswlbHaFa29ucZOit89l8wE-O8HkZu_b6qMOrA4fMJPs9tTDGqGbzm_9nr78csi_usEsLXVrmvhqTD308mrEeQoyDdfuiYKQ2M6B2M6C2M5Adnt0t5R7_0_T0F4LO-04</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Won, Eun Jeong</creator><creator>Choi, Min Ji</creator><creator>Kim, Mi-Na</creator><creator>Yong, Dongeun</creator><creator>Lee, Wee Gyo</creator><creator>Uh, Young</creator><creator>Kim, Taek Soo</creator><creator>Byeon, Seung Ah</creator><creator>Lee, Seung Yeob</creator><creator>Kim, Soo Hyun</creator><creator>Shin, Jong Hee</creator><general>U.S. National Center for Infectious Diseases</general><general>Centers for Disease Control and Prevention</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>202103</creationdate><title>Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008-2018</title><author>Won, Eun Jeong ; Choi, Min Ji ; Kim, Mi-Na ; Yong, Dongeun ; Lee, Wee Gyo ; Uh, Young ; Kim, Taek Soo ; Byeon, Seung Ah ; Lee, Seung Yeob ; Kim, Soo Hyun ; Shin, Jong Hee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c688t-47c3a38ed4875a2f9be13943c86e01cd4aa5cd3328cdf1101030ff086f1d35273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Amino acids</topic><topic>Antifungal agents</topic><topic>Antimicrobial agents</topic><topic>Bloodstream Isolates, South Korea, 2008–2018</topic><topic>Candida</topic><topic>Candida glabrata</topic><topic>candidemia</topic><topic>Causes of</topic><topic>Drug resistance in microorganisms</topic><topic>fluconazole resistance</topic><topic>Fluconazole-Resistant</topic><topic>fungal infections</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Laboratories</topic><topic>Mortality</topic><topic>Mutation</topic><topic>Patient outcomes</topic><topic>PDR1</topic><topic>Septicemia</topic><topic>Survival analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Won, Eun Jeong</creatorcontrib><creatorcontrib>Choi, Min Ji</creatorcontrib><creatorcontrib>Kim, Mi-Na</creatorcontrib><creatorcontrib>Yong, Dongeun</creatorcontrib><creatorcontrib>Lee, Wee Gyo</creatorcontrib><creatorcontrib>Uh, Young</creatorcontrib><creatorcontrib>Kim, Taek Soo</creatorcontrib><creatorcontrib>Byeon, Seung Ah</creatorcontrib><creatorcontrib>Lee, Seung Yeob</creatorcontrib><creatorcontrib>Kim, Soo Hyun</creatorcontrib><creatorcontrib>Shin, Jong Hee</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints in Context (Gale)</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Family Health Database (Proquest)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Emerging infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Won, Eun Jeong</au><au>Choi, Min Ji</au><au>Kim, Mi-Na</au><au>Yong, Dongeun</au><au>Lee, Wee Gyo</au><au>Uh, Young</au><au>Kim, Taek Soo</au><au>Byeon, Seung Ah</au><au>Lee, Seung Yeob</au><au>Kim, Soo Hyun</au><au>Shin, Jong Hee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008-2018</atitle><jtitle>Emerging infectious diseases</jtitle><addtitle>Emerg Infect Dis</addtitle><date>2021-03</date><risdate>2021</risdate><volume>27</volume><issue>3</issue><spage>779</spage><epage>788</epage><pages>779-788</pages><issn>1080-6040</issn><eissn>1080-6059</eissn><abstract>We investigated the clinical outcomes and molecular mechanisms of fluconazole-resistant (FR) Candida glabrata bloodstream infections. Among 1,158 isolates collected during multicenter studies in South Korea during 2008–2018, 5.7% were FR. For 64 patients with FR bloodstream infection isolates, the 30-day mortality rate was 60.9% and the 90-day mortality rate 78.2%; these rates were significantly higher than in patients with fluconazole-susceptible dose-dependent isolates (30-day mortality rate 36.4%, 90-day mortality rate 43.8%; p&lt;0.05). For patients with FR isolates, appropriate antifungal therapy was the only independent protective factor associated with 30-day (hazard ratio 0.304) and 90-day (hazard ratio 0.310) mortality. Sequencing of pleiotropic drug-resistance transcription factor revealed that 1–2 additional Pdr1p amino acid substitutions (except genotype-specific Pdr1p amino acid substitutions) occurred in 98.5% of FR isolates but in only 0.9% of fluconazole-susceptible dose-dependent isolates. These results highlight the high mortality rate of patients infected with FR C. glabrata BSI isolates harboring Pdr1p mutations.</abstract><cop>United States</cop><pub>U.S. National Center for Infectious Diseases</pub><pmid>33624581</pmid><doi>10.3201/eid2703.203482</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1080-6040
ispartof Emerging infectious diseases, 2021-03, Vol.27 (3), p.779-788
issn 1080-6040
1080-6059
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_3ccd79ff7cc8478e942f8f34a54809c6
source PubMed Central
subjects Amino acids
Antifungal agents
Antimicrobial agents
Bloodstream Isolates, South Korea, 2008–2018
Candida
Candida glabrata
candidemia
Causes of
Drug resistance in microorganisms
fluconazole resistance
Fluconazole-Resistant
fungal infections
Gene expression
Genetic aspects
Health aspects
Laboratories
Mortality
Mutation
Patient outcomes
PDR1
Septicemia
Survival analysis
title Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008-2018
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A06%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fluconazole-Resistant%20Candida%20glabrata%20Bloodstream%20Isolates,%20South%20Korea,%202008-2018&rft.jtitle=Emerging%20infectious%20diseases&rft.au=Won,%20Eun%20Jeong&rft.date=2021-03&rft.volume=27&rft.issue=3&rft.spage=779&rft.epage=788&rft.pages=779-788&rft.issn=1080-6040&rft.eissn=1080-6059&rft_id=info:doi/10.3201/eid2703.203482&rft_dat=%3Cgale_doaj_%3EA656636379%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c688t-47c3a38ed4875a2f9be13943c86e01cd4aa5cd3328cdf1101030ff086f1d35273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2509961958&rft_id=info:pmid/33624581&rft_galeid=A656636379&rfr_iscdi=true